Even as drug molecules become increasingly complex, solid form characterization provides drug development scientists with the insights they need to accelerate the development of their new pharmaceutical products.
In this second webinar of the ‘Solid form analysis’ webinar series, we will showcase how X-ray Powder Diffraction (XRPD) can make active pharmaceutical ingredient (API) candidate selection process more productive and efficient. This presentation will consider the pharmaceutical development workflow and map onto it the appropriate X-ray diffraction & scattering methods specifically for the early development stage. Join us as our experts chart the path from candidate molecule synthesis to lead candidate selection, using a range of structural solid form characterization methods.
- Discover why chemistry acumen is vital for successful drug discovery.
- Learn how applying a multi-technique approach provides the most robust mechanism for selecting lead candidates.
- Understand how to detect even the slightest changes that can put the performance of your manufactured drug substance/product at risk.
Speakers
- Natalia Dadivanyan - Subject Matter Expert - Segment Manager for Small Molecule Pharmaceuticals, Malvern Panalytical
More information
Who should attend?
- Anyone working in early and late development of pharmaceuticals
- Anyone involved in manufacturing of drug products
- Anyone engaged in method development
What will you learn?
- Discover why chemistry acumen is vital for successful drug discovery.
- Learn how applying a multi-technique approach provides the most robust mechanism for selecting lead candidates.
- Understand how to detect even the slightest changes that can put the performance of your manufactured drug substance/product at risk.
- Discover why chemistry acumen is vital for successful drug discovery.